885280-71-7

Basic information

• Product Name: 7-BROMO-1,2,3,4-TETRAHYDRO-NAPHTHALEN-2-YLAMINE
• Synonyms: 7-BROMO-1,2,3,4-TETRAHYDRO-NAPHTHALEN-2-YLAMINE;7-Bromo-1,2,3,4-tetrahydronaphthalen-2-amine;2-Naphthalenamine, 7-bromo-1,2,3,4-tetrahydro-;7-bromo-1,2,3,4-tetrahydro-2-Naphthalenamine
• CAS NO: 885280-71-7
• Molecular Formula: C₁₀H₁₂BrN
• Molecular Weight: 226.11
• Mol File: 885280-71-7.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 298.7±40.0 °C(Predicted)
• Appearance: /
• Density: 1.413±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C(protect from light)
• PKA: 10.03±0.20(Predicted)
• CAS DataBase Reference: 7-BROMO-1,2,3,4-TETRAHYDRO-NAPHTHALEN-2-YLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 7-BROMO-1,2,3,4-TETRAHYDRO-NAPHTHALEN-2-YLAMINE(885280-71-7)
• EPA Substance Registry System: 7-BROMO-1,2,3,4-TETRAHYDRO-NAPHTHALEN-2-YLAMINE(885280-71-7)

Safety Data

• Hazardous Substances Data: 885280-71-7(Hazardous Substances Data)

Usage

General Description

7-Bromo-1,2,3,4-tetrahydro-naphthalen-2-ylamine is a chemical compound with the molecular formula C10H12BrN. It is a derivative of naphthalene and contains a bromine atom as well as an amine functional group. 7-BROMO-1,2,3,4-TETRAHYDRO-NAPHTHALEN-2-YLAMINE is used in the field of medicinal chemistry for the development of potential drug candidates due to its pharmacological properties. It may also be utilized as a building block in organic synthesis for the creation of various chemical compounds. The presence of both the bromine and amine groups make this compound a versatile intermediate in the synthesis of diverse organic materials. Furthermore, its specific structure and properties make it of interest in various research and industrial applications.

InChI:InChI=1S/C10H12BrN/c11-9-3-1-7-2-4-10(12)6-8(7)5-9/h1,3,5,10H,2,4,6,12H2

Upstream product

• 132095-54-6 7-bromo-2-tetralone 

Downstream Products

• 1364164-16-8 3-(4-fluoroanilino)tetralin-6-carbohydroxamic acid 
• 1364165-64-9 C₁₈H₁₈FNO₂ 
• 1364164-43-1 3-[[4-(2-chlorophenyl)pyrimidin-2-yl]amino]tetralin-6-carbohydroxamic acid 
• 1364164-41-9 3-[[4-(3-chlorophenyl)pyrimidin-2-yl]amino]tetralin-6-carbohydroxamic acid 
• 1364164-39-5 3-[[4-(4-chlorophenyl)pyrimidin-2-yl]amino]tetralin-6-carbohydroxamic acid 
• 1364164-33-9 3-[(4-phenylpyrimidin-2-yl)amino]tetralin-6-carbohydroxamic acid 
• 1364164-22-6 3-(3-chloro-4-cyanoanilino)tetralin-6-carbohydroxamic acid 
• 1364166-14-2 C₁₈H₁₇Cl₂NO₄S 
• 1364166-11-9 C₁₈H₁₇Cl₂NO₄S 
• 1364166-08-4 C₂₀H₂₃NO₆S 
• 1364166-05-1 C₁₈H₁₇F₂NO₄S 
• 1364166-02-8 C₁₉H₁₈F₃NO₄S 
• 1364165-99-0 C₁₈H₁₈ClNO₄S 
• 1364165-96-7 C₁₈H₁₈ClNO₄S 

Relevant articles and documents

Identification of a novel aminotetralin class of HDAC6 and HDAC8 selective inhibitors

Herein we report the identification of a novel class of HDAC6 and HDAC8 selective inhibitors through a unique chemistry and phenotypic screening strategy. Tetrahydroisoquinoline 12 was identified as a potent HDAC6 and HDAC8 dual inhibitor from a focused l

NOVEL N-HYDROXY-BENZAMIDES FOR THE TREATMENT OF CANCER

The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt, ester or stereoisomer thereof, wherein R1 to R3 and X have the significances given herein. The present invention is also directed to proc